Untargeted metabolomics can decide hereditary variation to improve understanding finding Kumar Jeetendra | July 8, 2020 A family and patient walk into a physician’s office. They expect that the most recent tests will show what’s causing the individual’s disease and finish the diagnostic odyssey they’ve been going through for ages. Possessing a precise identification also suggests that perhaps there’s a remedy that can relieve the individual’s condition. To identify the genetic …
New T-cell-based immunization procedure gives more extensive insurance against occasional flu Kumar Jeetendra | September 24, 2020 As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple …
FDA-endorsed COVID-19 medication should be utilized warily, says UC researcher Kumar Jeetendra | January 4, 2021 While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics continue to be necessary to treat hepatitis patients. One of these treatments, remdesivir, is the first and only antiviral agent of its type the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19. Research at the University …
